Share on StockTwits

Roka Bioscience (NASDAQ:ROKA) released its earnings data on Monday. The company reported ($11.28) EPS for the quarter, Stock Ratings News reports. The company had revenue of $1.40 million for the quarter.

Shares of Roka Bioscience (NASDAQ:ROKA) traded up 1.91% during mid-day trading on Monday, hitting $10.69. The stock had a trading volume of 6,838 shares. Roka Bioscience has a one year low of $9.15 and a one year high of $13.00. The stock’s 50-day moving average is $10. and its 200-day moving average is $10.. The company’s market cap is $188.5 million.

ROKA has been the subject of a number of recent research reports. Analysts at Cowen and Company initiated coverage on shares of Roka Bioscience in a research note on Monday. They set an “outperform” rating and a $13.00 price target on the stock. On a related note, analysts at Wedbush initiated coverage on shares of Roka Bioscience in a research note on Monday. They set an “outperform” rating and a $15.00 price target on the stock. Finally, analysts at Leerink Swann initiated coverage on shares of Roka Bioscience in a research note on Monday. They set an “outperform” rating and a $13.00 price target on the stock.

Roka Bioscience, Inc is a molecular diagnostics company. The Company focuses on advanced testing solutions for the detection of foodborne pathogens.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.